WuXi Biologics’ biosafety and cell characterization testing facilities are located in Suzhou and Shanghai.
Our high-quality services include:
- Viral clearance/inactivation studies
- Cell line characterization
- Unprocessed bulk lot release testing services
As the first non-state affiliated lab of its type in China and Asia, WuXi Biologics is one of the rare CDMOs that offer in-house biosafety testing capabilities. These capabilities allow WuXi Biologics to reduce our clients’ drug development timelines because we eliminate the problematic hand-offs inherent in the historic multiple vendor model. If using our standard cell line, cell culture and purification technology platforms these timelines can be streamlined even further.
Unprocessed Bulk Lot Release
Cell harvest material/unprocessed bulk must be tested for the presence of adventitious virus and mycoplasma. WuXi Biologics offers in vitro and molecular biology (qPCR) approaches under GLP and GMP standards for detection of these microorganisms.